Entero Therapeutics, Inc. (ENTO) — Cash Flow Reinvestment Rate
Entero Therapeutics, Inc. (ENTO) has a Cash Flow Reinvestment Rate of 0.00x as of June 2014, reinvesting $0.00 (capex $0.00 ) from operating cash flow of $129.24. Check earnings quality score of Entero Therapeutics, Inc. to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Entero Therapeutics, Inc. Cash Flow Reinvestment Rate (2013–2013)
Historical reinvestment intensity for Entero Therapeutics, Inc. across 1 annual periods. Explore ENTO operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Entero Therapeutics, Inc. (2013–2013)
Year-by-year capital reinvestment analysis for Entero Therapeutics, Inc.. For live market cap and broader valuation context, see Entero Therapeutics, Inc. (ENTO) total market value.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2013 | 0.00x | $0.00 | $56.55 | $0.00 | — |